Duo Oncology Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8M
- Investors
-
10
Duo Oncology General Information
Description
Developer of nanoparticle technology intended to redefine the treatment landscape for patients with pancreatic cancer and other hard-to-treat tumors. The company's technology specializes in transforming outcomes with a new type of monotherapy to improve the care for patients with pancreatic cancer, bile duct cancer, and relapsed metastatic disease, compelling data, addresses indications in immunotherapy and precision medicine, thereby enabling patients to recover at a fast speed and efficiency.
Contact Information
Website
www.duooncology.comCorporate Office
- 4165 Blair Street
- Pittsburgh, PA 15207
- United States
Corporate Office
- 4165 Blair Street
- Pittsburgh, PA 15207
- United States
Duo Oncology Timeline
Duo Oncology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Early Stage VC (Series A) | $8M | Completed | Pre-Clinical Trials | |||
5. Accelerator/Incubator | 21-Mar-2024 | Completed | Pre-Clinical Trials | |||
4. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
3. Grant | 27-Oct-2023 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 11-Aug-2023 | $4.25M | $4.25M | Completed | Pre-Clinical Trials | |
1. Accelerator/Incubator | 03-Nov-2020 | Completed | Pre-Clinical Trials |
Duo Oncology Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed | ||||||||
Seed-1 |
Duo Oncology Comparisons
Industry
Financing
Details
Duo Oncology Competitors (47)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genprex | Formerly VC-backed | Austin, TX | ||||
MiNA Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
CytImmune Sciences | Private Equity-Backed | Rockville, MD | ||||
Innocare | Formerly VC-backed | Beijing, China |
Duo Oncology Signals
Duo Oncology Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Cancer Institute I-Corps | Accelerator/Incubator | |||
U.S. Department of Health and Human Services | Government | |||
BeiGene | Corporation | Minority | ||
Innovation Works | Venture Capital | Minority | ||
NuFund Venture Group | Angel Group | Minority |
Duo Oncology FAQs
-
When was Duo Oncology founded?
Duo Oncology was founded in 2020.
-
Where is Duo Oncology headquartered?
Duo Oncology is headquartered in Pittsburgh, PA.
-
What is the size of Duo Oncology?
Duo Oncology has 4 total employees.
-
What industry is Duo Oncology in?
Duo Oncology’s primary industry is Discovery Tools (Healthcare).
-
Is Duo Oncology a private or public company?
Duo Oncology is a Private company.
-
What is the current valuation of Duo Oncology?
The current valuation of Duo Oncology is
. -
What is Duo Oncology’s current revenue?
The current revenue for Duo Oncology is
. -
How much funding has Duo Oncology raised over time?
Duo Oncology has raised $12.7M.
-
Who are Duo Oncology’s investors?
National Cancer Institute I-Corps, U.S. Department of Health and Human Services, BeiGene, Innovation Works, and NuFund Venture Group are 5 of 10 investors who have invested in Duo Oncology.
-
Who are Duo Oncology’s competitors?
Genprex, MiNA Therapeutics, Cristal Therapeutics, CytImmune Sciences, and Innocare are some of the 47 competitors of Duo Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »